Bioworkshops sell "Nirsevimab"
Basic Information
260
18
5
4.9(27)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Nirsevimab
Manufacturer(s)
Specifications
- Expression System: mAb (CAS 1989556-22-0) developed from a DMF-filed cell line, targeting the RSV F protein.
- Regulatory Status: Approved 31/10/2022 in the EU/Iceland/Liechtenstein/Norway for RSV-related pneumonia in infants.
- Purity: High degree of analytical similarity to the reference product, produced via an optimized, high-titer cell line and process.
Documents
GMP
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment